Technical Analysis for BXN - Bioxyne Ltd  

Grade Last Price % Change Price Change
F 0.007 -22.22% -0.002
BXN closed down 22.22 percent on Wednesday, April 24, 2024, on 31 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -22.22%

   Recent Intraday Alerts

Alert Time
Down 10% 1 day ago
Down 2 ATRs 1 day ago
Down 1 ATR 1 day ago
Fell Below Previous Day's Low 1 day ago
Down 5% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bioxyne Limited is an Australia-based bio-technology company engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company has an agreement to manufacture, market, supply and distribute its probiotic strain for over the counter dietary supplement products. Its segments include Probiotics and Other. It focuses on immune health and immunotherapeutic products. The Company's focus is on its probiotic business and product Lactobacillus fermentum PCC. The Company holds an interest in Mariposa Health Limited, a pharmaceutical development company with a focus on Congestive and Obstructive Pulmonary Disease (COPD).
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Disease Medical Specialties Therapeutic Product Therapeutic Products Bacteria Bacteriology Microbiology Over The Counter Dietary Supplement Copd Dietary Supplements Probiotic Bio Technology Digestive System Immunotherapeutic Products Pharmaceutical Development

Is BXN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.029
52 Week Low 0.007
Average Volume 771,129
200-Day Moving Average 0.015
50-Day Moving Average 0.010
20-Day Moving Average 0.009
10-Day Moving Average 0.009
Average True Range 0.001
RSI (14) 45.05
ADX 13.22
+DI 25.781
-DI 35.938
Chandelier Exit (Long, 3 ATRs) 0.009
Chandelier Exit (Short, 3 ATRs) 0.010
Upper Bollinger Bands 0.012
Lower Bollinger Band 0.007
Percent B (%b) -0.05
BandWidth 46.809
MACD Line -0.001
MACD Signal Line -0.001
MACD Histogram 0.0
Fundamentals Value
Market Cap 4.48 Million
Num Shares 640 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio -3.50
Price-to-Sales 3.40
Price-to-Book 3.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.007
Resistance 3 (R3) 0.007 0.007 0.007
Resistance 2 (R2) 0.007 0.007 0.007 0.007
Resistance 1 (R1) 0.007 0.007 0.007 0.007 0.007
Pivot Point 0.007 0.007 0.007 0.007 0.007
Support 1 (S1) 0.007 0.007 0.007 0.007 0.007
Support 2 (S2) 0.007 0.007 0.007 0.007
Support 3 (S3) 0.007 0.007 0.007
Support 4 (S4) 0.007